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Background—It has been proposed that activation of endothelial SK3 (KCa2.3) and IK1 (KCa3.1) K channels plays a role
in the arteriolar dilation attributed to an endothelium-derived hyperpolarizing factor (EDHF). However, our under-
standing of the precise function of SK3 and IK1 in the EDHF dilator response and in blood pressure control remains
incomplete. To clarify the roles of SK3 and IK1 channels in the EDHF dilator response and their contribution to blood
pressure control in vivo, we generated mice deficient for both channels.
Methods and Results—Expression and function of endothelial SK3 and IK1 in IK1//SK3T/T mice was characterized by
patch-clamp, membrane potential measurements, pressure myography, and intravital microscopy. Blood pressure was
measured in conscious mice by telemetry. Combined IK1/SK3 deficiency in IK1//SK3T/T (doxycycline) mice
abolished endothelial KCa currents and impaired acetylcholine-induced smooth muscle hyperpolarization and EDHF-
mediated dilation in conduit arteries and in resistance arterioles in vivo. IK1 deficiency had a severe impact on
acetylcholine-induced EDHF-mediated vasodilation, whereas SK3 deficiency impaired NO-mediated dilation to
acetylcholine and to shear stress stimulation. As a consequence, SK3/IK1-deficient mice exhibited an elevated arterial
blood pressure, which was most prominent during physical activity. Overexpression of SK3 in IK1//SK3T/T mice
partially restored EDHF- and nitric oxide–mediated vasodilation and lowered elevated blood pressure. The IK1-opener
SKA-31 enhanced EDHF-mediated vasodilation and lowered blood pressure in SK3-deficient IK1//SK3T/T (doxy-
cycline) mice to normotensive levels.
Conclusions—Our study demonstrates that endothelial SK3 and IK1 channels have distinct stimulus-dependent functions, are
major players in the EDHF pathway, and significantly contribute to arterial blood pressure regulation. Endothelial KCa
channels may represent novel therapeutic targets for the treatment of hypertension. (Circulation. 2009;119:2323-2332.)
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The arterial endothelium modulates the contractile state ofthe underlying vascular smooth muscle and thus blood
pressure by releasing the vasodilating autacoids nitric oxide
(NO)1 and prostacyclin (prostaglandinI2 [PGI2]).2 Besides NO
and PGI2, a third factor or signaling pathway termed endo-
thelium-derived hyperpolarizing factor (EDHF)3 adds to en-
dothelium-dependent vasodilation by causing hyperpolariza-
tion and relaxation of vascular smooth muscle. Although
EDHF has been proposed to be as powerful3–5 as NO and
PGI2 in controlling vascular tone and blood pressure, direct
evidence for this is missing. Moreover, the molecular identi-
ties of EDHF and the EDHF-signaling pathways are still a
matter of ongoing debate. Indeed, EDHF dilatory responses
have been attributed to a variety of diffusible EDHFs such as
cytochrome P450–generated metabolites of arachidonic ac-
id,6,7 lipoxygenase products,8 NO itself,9 hydrogen perox-
ide,10 and C-type natriuretic peptide,11 as well as to electro-
tonic coupling12 of endothelium and smooth muscle (for
extensive review, see References 3 and 5). Whatever EDHF
might be, activation of the Ca2-activated K channels SK3
(KCa2.3)13 and IK1 (KCa3.1),14 located in the endothelium,15–18
has been proposed to initiate EDHF signaling in a variety of
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vascular beds and species.17–20 On intracellular Ca2 mobili-
zation in response to receptor stimulation by pharmacological
stimuli, SK3 and IK1 mediate K efflux and produce mem-
brane hyperpolarization.16,18 This endothelial hyperpolariza-
tion and/or the concomitant K efflux17 causes subsequent
smooth muscle hyperpolarization, leading to the closure of
voltage-activated Ca2 channels and finally relaxation. How-
ever, the concept that IK1 and SK3 are required to initiate the
EDHF dilator response is based mainly on studies of isolated
vessels and pharmacological evidence.3,5,17,18 Recently, we
reported that IK1-deficient mice (IK1/) exhibit a partial
defect in EDHF signaling and a moderately elevated blood
pressure.20 Genetic modulation of SK3 expression in mice21
has also been shown to alter blood pressure.22 In these SK3T/T
mice, expression levels of SK3 are controlled by site-specific
insertion of a tetracycline-based genetic switch.21 Dietary
doxycycline administration dramatically diminished SK3 ex-
pression, whereas the channel is overexpressed3-fold in the
absence of doxycycline.21 Although SK3 suppression by
doxycycline treatment causes a substantial elevation of blood
pressure,22 it is unknown whether the higher blood pressure in
SK3T/T (doxycycline) mice is related to defects in EDHF
signaling. Thus, the understanding of the specific roles of
SK3 and IK1 in the EDHF dilator response and the contri-
bution of EDHF to endothelial control of vascular tone, and
ultimately blood pressure in vivo, is incomplete.3,5 To eluci-
date the roles of SK3 and IK1, we generated mice deficient
for both channels (IK1//SK3T/Tdoxycycline) and studied
signaling related to EDHF as well as arterial blood pressure in
these mice. The present study identifies endothelial SK3 and
IK1 channels as major effectors in EDHF signaling in vivo
and reveals their significant impact on systemic blood pres-
sure control.
Clinical Perspective on p 2332
Methods
IK1/SK3T/T animals were generated by interbreeding SK3T/T mice
and IK1/ mice and genotyped by polymerase chain reaction. For
suppression of SK3, mice received doxycycline in the drinking water
(2 mg/mL, 2% sucrose) for at least 6 days. SK3/IK1 expression was
detected by Western blot analysis of brain (SK3) and liver extracts
(IK1). Vascular SK3/IK1 expression was detected by immunohisto-
chemistry on carotid arteries (CA). Whole-cell IK1/SK3 currents
were recorded in freshly isolated CA endothelial cells with the use of
patch-clamp and smooth muscle membrane potentials in CA by
sharp-electrode techniques. Endothelium-dependent and -independent
vasodilation was studied by pressure myography in CA and intravital
microscopy of resistance arterioles in the cremaster muscle in vivo.
Arterial blood pressure, heart rate, and locomotor activity were mea-
sured telemetrically in freely moving mice for at least 3 consecutive
days in the presence or absence of doxycycline or 24 hours before and
after injection of the IK1-opener SKA-31.
Statistical Analysis
Data are given as meanSEM. One-way ANOVA tests followed by
Newman-Keuls or Bonferroni post hoc tests or paired Student t test
were used as indicated to assess differences between groups.
For a detailed description of Methods, see the online-only Data
Supplement.
Results
Generation of IK1//SK3T/T Mice
IK1/ and SK3T/T mice were generated as described previ-
ously20,21 and interbred to generate IK1//SK3T/T (Figure
1A). IK1//SK3T/T offspring were viable, fertile, and had no
overt behavioral or neurological defects with or without
doxycycline administration. In IK1X/SK3T/T mice, dietary
doxycycline for at least 6 days virtually abolished SK3
expression in brain (Figure 1B). In IK1//SK3X, loss of IK1
protein was confirmed in liver (Figure 1B). Immunohisto-
chemistry demonstrated loss of endothelial SK3 and IK1
from IK1//SK3T/Tdoxycycline and overexpression of SK3
in IK1//SK3T/Tdoxycycline (Figure 1C).
Combined IK1 and SK3 Suppression Abolishes
Endothelial KCa Currents and Reduces
Endothelium-Mediated Smooth
Muscle Hyperpolarization
Endothelial IK1/SK3 functions were determined by whole-
cell patch-clamp experiments20 on freshly isolated CA endo-
Figure 1. Generation of IK1//SK3T/T mice. A, Polymerase chain
reaction amplified SK3 WT () and tTA-targeted (T) alleles (top)
as well as IK1 WT () and targeted alleles () (bottom). Note
homozygous IK1//SK3T/T mice on right. B, top, Western blot of
SK3 protein in brain from IK1//SK3X mice /doxycycline
(DOX) for 2 weeks. *The apparent smaller size of the protein in
IK1//SK3T/Tdoxycycline is due to the deletion of 40 AA from
the n-terminus. Middle, IK1 was not detected in liver from
IK1//SK3X mice. Visualization of -tubulin demonstrates equal
loading. Bottom, IK1 in liver from IK1//SK3X mice. C, Immuno-
histochemistry of SK3 (top) and IK1 (bottom) expression in en-
dothelium of CA. Note the absence of specific IK1 and SK3
staining in endothelium of IK1//SK3T/Tdoxycycline and the
intense SK3 staining in IK1//SK3T/Tdoxycycline compared
with WT. Me indicates media; Lu, lumen; and En, endothelium.
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thelial cells (Figure 2A through 2G). On Ca2 dialysis,
wild-type (WT) CA endothelial cells showed a K current
that was abolished by a combination of the IK1 blocker
TRAM-3423 (1 mol/L) and the SK blocker UCL168424 (1
mol/L). After suppression of SK3 by dietary doxycycline,
the amplitude of this K current was reduced by 50% in
SK3T/T mice, and the remaining K current was inhibited by
TRAM-34. TRAM-34 unmasked a small UCL1684-sensitive
current, indicating that the doxycycline treatment reduced
SK3 expression by 90%.22 The total K current was
reduced to a similar extent in IK1/ mice, and the residual
current was abolished by UCL1684. In doxycycline-
administered IK1//SK3T/T mice, the K current was virtu-
ally abolished, and the very small residual K current was
sensitive to UCL1684. In contrast, the UCL1684-sensitive K
current was 10-fold larger in untreated IK1//SK3T/T mice
compared with the composite K current in WT CA endo-
thelial cells, which reflects the overexpression of SK3. In
doxycycline-administered IK1//SK3T/T mice, the IK1-
opener SKA-31(naphtho[1,2-d]thiazol-2-ylamine)25 (500
nmol/L) enhanced the TRAM-34–sensitive K currents by 2-
to 3-fold, thus strongly potentiating IK1 currents, without an
appreciable effect on the residual UCL1684-sensitive SK3
current.
To study endothelial IK1/SK3-mediated hyperpolarization
of smooth muscle to acetylcholine (100 nmol/L), we per-
formed sharp-electrode measurements of smooth muscle
membrane potentials in pressurized (80 mm Hg) and precon-
stricted (phenylephrine, 1 mol/L) CA, as shown in Figure 3.
In WT, acetylcholine elicited a robust hyperpolarization from
a resting membrane potential of 401 to 614 mV.
Suppression of SK3 (SK3T/Tdoxycycline) slightly reduced
the hyperpolarization to acetylcholine (from 401 to
571 mV; P0.05 versus WT). In IK1/, the hyperpolar-
ization response was markedly reduced (from 401 to
511 mV; P0.01 versus WT and SK3T/Tdoxycycline).
Figure 2. IK1 and SK3 currents in CA endothelial cells. Scheme on left illustrates whole-cell patch-clamp experiments in freshly iso-
lated CA endothelial cells. VSMC indicates vascular smooth muscle cells. A, Current-voltage relationship of composite IK1 and SK3
currents in CA endothelial cells from WT. Currents were reduced by the SK blocker UCL1684 (1 mol/L) and abolished by additional
application of the IK1 blocker TRAM-34 (1 mol/L). B, Reduced currents in CA endothelial cells from IK1//SK3T/Tdoxycycline (Dox).
The residual, largely IK1-mediated current was inhibited by TRAM-34. A minor TRAM-34–resistant current was blocked by UCL1684.
C, Reduced currents in IK1//SK3/ CA endothelial cells and inhibition of the residual SK3 current by UCL1684. D, Absence of IK1
and almost complete suppression of SK3 currents in IK1//SK3T/T(doxycycline). E, Overexpression of SK3 in IK1//SK3T/T
doxycycline resulted in large, UCL1684-sensitive currents. F, In IK1//SK3T/Tdoxycycline, the IK1-opener SKA-31 (500 nmol/L)
strongly potentiated the IK1-mediated current (sensitive to TRAM-34). UCL1684 blocked the small residual current. G, Summary data
for K currents at 0 mV in all groups. Values are given as meanSE; numbers (n) in charts refer to number of CA endothelial cells.
*P0.05, **P0.01 vs WT; #P0.05 vs IK1//SK3T/Tdoxycycline, 1-way ANOVA followed by Newman-Keuls post hoc test.
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In CA from IK1//SK3T/Tdoxycycline, the hyperpolariza-
tion response was attenuated even further (from 391 to
451 mV; P0.01 versus other groups). However, in CA
that lacked IK1 and overexpressed SK3 (IK1//SK3T/T
doxycycline), we observed a restoration (from 391 to
581 mV), and the response was not different from WT.
Interestingly, potentiation of IK1 functions by SKA-31 in
IK1//SK3T/Tdoxycycline strongly enhanced acetylcholine-
induced hyperpolarization (from 412 to 781 mV;
P0.01).
Loss of Endothelial IK1 and SK3 Channels
Disrupts the EDHF Dilator Response
We next examined EDHF-type vasodilation in pressurized
and preconstricted CA20 using a “classic” EDHF protocol3 in
which we blocked NO synthase using N-nitro-L-arginine
(L-NNA) (300 mol/L) and cyclooxygenase using indometh-
acin (10 mol/L) to eliminate NO-mediated and, although
unlikely in these murine vessels, prostacyclin-mediated va-
sodilations.20 Figure 4A shows representative tracings of
acetylcholine-induced EDHF-type vasodilations for WT,
IK1/, IK1//SK3T/Tdoxycycline, and IK1//SK3T/T
doxycycline. For concentration-response curves from all
groups, see Figure 4B. Intraluminally applied acetylcholine
(100 nmol/L) produced a robust EDHF-type vasodilation in
WT. In contrast, in CA from IK1//SK3/, vasodilation to
100 nmol/L acetylcholine was reduced by 75% (P0.001),
and in CA from IK1//SK3T/Tdoxycycline, 100 nmol/L
acetylcholine induced virtually no dilation (99% reduction;
P0.001; Figure 4B, left panel). EDHF-type vasodilation to
100 nmol/L acetylcholine was not significantly altered in IK1//
SK3T/Tdoxycycline as well as in SK3-overexpressing IK1//
SK3T/Tdoxycycline (Figure 4B, right panel). However, in
CA from mice lacking IK1/ and overexpressing SK3, the
EDHF-type vasodilation was restored. Potentiation of IK1
functions by SKA-31 in SK3T/T/IK1/doxycycline caused
a significant increase of amplitude and duration of EDHF-
type vasodilation to 10 and 100 nmol/L acetylcholine (Figure
4C), which reflects a left shift of the concentration-response
curve.
We performed a second set of experiments in the absence
of L-NNA and indomethacin to evaluate combined NO- and
EDHF-mediated vasodilation to acetylcholine (Figure 4D).
Under these conditions, acetylcholine (100 nmol/L) produced
a 1.5-fold larger vasodilation in WT because of the contri-
bution of NO. With intact NO synthesis, the vasodilation to
100 nmol/L acetylcholine was equally reduced by 30% in
CA from IK1/ (P0.05) and IK1//SK3T/Tdoxycycline
(P0.01). Interestingly, the deficit of SK3 and IK1 impaired
the NO-mediated vasodilation at a lower acetylcholine con-
centration of 10 nmol/L (P0.05; insert in Figure 4D, left
panel). A similar impairment was caused by the lack of SK3
alone in SK3T/Tdoxycycline (P0.05; insert in Figure 4D,
right panel), which suggests an additional role for SK3 in NO
production elicited by low levels of circulating vasoactive
factors. In CA from IK1X/SK3T/Tdoxycycline, which over-
expressed SK3, vasodilation was similar to WT. Endotheli-
um-independent vasodilations to sodium nitroprusside (10
mol/L), vasoconstriction on phenylephrine (1 mol/L), and
elevated K (60 mmol/L) were similar in all genotypes
(Figure 4A and Figure I in the online-only Data Supplement).
Because EDHF has been reported to play a prominent
role in the microcirculation, we next investigated the
contribution of IK1 and SK3 in EDHF-type and NO/
EDHF-mediated vasodilation in resistance-sized arterioles
of the cremaster microcirculation in vivo by intravital
microscopy.26,27 This in vivo technique allows monitoring
of arteriolar diameters during superfusion of vasoactive
compounds. In the presence of inhibitors of NO synthase/
cyclooxygenase, acetylcholine (1 mol/L) produced sig-
nificant vasodilation in WT, which was abolished in
IK1//SK3T/Tdoxycycline (P0.01) (Figure 4E). With
intact NO synthase/cyclooxygenase, acetylcholine induced
a comparable dilation in WT (Figure 4E, left panel), which
Figure 3. Sharp-electrode measurements of smooth muscle membrane potentials in pressurized, constricted CA (illustrated by picture
in top panel). Left, Representative recordings before and during application of acetylcholine (100 nmol/L, arrow) are shown. Luminal
concentration of SKA-31 was 500 nmol/L. Right, Change of membrane potential (MP) from different groups. Dox indicates doxycy-
cline. Values are given as meanSE; numbers (n) in charts refer to number of CA. *P0.05, **P0.01 vs WT, 1-way ANOVA followed
by Newman-Keuls post hoc test; #P0.01 vs IK1//SK3T/Tdoxycycline.
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Figure 4. Impact of IK1/SK3 deficiency on acetylcholine-induced vasodilation in CA and in arterioles. A, Original tracings show
increases in diameter (EDHF-type vasodilation) in response to increasing concentrations of acetylcholine (ACh) (numbers in graphs,
9 to 5logM [acetylcholine]) and to 10 mol/L sodium nitroprusside (SNP). CA were preconstricted with phenylephrine (PE)
(1 mol/L) and pressurized to 80 mm Hg (illustrated in top panel on right). B, Concentration-response curves of acetylcholine-induced
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was also reduced by 50% in IK1//SK3T/Tdoxycycline. At
low concentrations of acetylcholine (100 nmol/L) only, dilations
were mainly NO mediated in WT, which was virtually absent in
IK1//SK3T/Tdoxycycline, indicating a contribution of endo-
thelial KCa channels to NO formation.
In a second set of experiments, we tested the contribution of
the individual KCa channels to EDHF-mediated vasodilation
(Figure 4E, right panel). The deficit of IK1 in IK1/ strongly
reduced EDHF dilator responses to acetylcholine (P0.05),
whereas the deficit of SK3 in IK1//SK3T/Tdoxycycline did
not reduce the dilation. The response at 3 mol/L acetylcholine
was apparently larger than in WT. Overexpression of SK3 in
IK1-deficient mice (IK1//SK3T/Tdoxycycline) increased di-
lations to WT levels or enhanced them even further (at 10
mol/L, P0.05). Acetylcholine dilations obtained during intact
NO synthase and cyclooxygenase were comparable to pure
EDHF-type responses in these genotypes (Figure IV in the
online-only Data Supplement), again demonstrating the insignif-
icant role of NO and prostaglandins in the absence of either
endothelial KCa channel. Endothelium-independent vasodilations
in response to sodium nitroprusside (10 mol/L) and dilations to
adenosine (1 and 10 mol/L) were similar in all groups (data not
shown). These findings in a conduit artery and in the cremaster
microcirculation suggest that IK1 channels are of major impor-
tance for EDHF-mediated dilations to acetylcholine and that
SK3 only contributes to the response if IK1 channels are absent.
Loss of Endothelial SK3 but Not of IK1 Channels
Impairs Wall Shear Stress–Induced
Dilator Responses
Endothelial ion channels have been suggested to contribute to
wall shear stress–induced arterial vasodilation and thus to
mechanisms of endothelial mechanotransduction of altered he-
modynamics.28 However, the specific contribution of either
SK3 or IK1 channels is unknown. To elicit wall shear stress–
mediated dilation in different groups, we increased the viscosity
of the perfusion medium by adding 5% dextran. In CA of WT,
the increase in viscosity elicited a small but appreciable EDHF-
type dilator response of14% (Figure 5A, presence of L-NNA/
indomethacin). In SK3T/Tdoxycycline, this wall shear stress–
induced dilation was reduced to 2% (P0.01) and was
attenuated to a similar extent in IK1//SK3T/Tdoxycycline
(5%; P0.05). In contrast, CA of IK1/ displayed dilations
similar to that observed in WT CA. Overexpression of SK3 in
IK1X/SK3T/Tdoxycycline did not affect this dilation. Similarly,
wall shear stress–induced dilation elicited by increasing flow
from 30 to 600 L/min was impaired in IK1X/SK3T/T
doxycycline, whereas it remained intact in IK1/ and IK1X/
SK3T/Tdoxycycline (Figure IIA in the online-only Data Sup-
plement). In the absence of inhibitors of NO/prostacyclin syn-
thesis, WT CA responded to wall shear stress stimulation by
high viscosity (Figure 5B) as well as by an increase of flow
(Figure IIB in the online-only Data Supplement) with more
pronounced dilations of 23% and 25%, respectively, due to
the contribution of NO.28 Again, this response was severely
impaired in IK1X/SK3T/Tdoxycycline, whereas it remained
intact in IK1/ and IK1X/SK3T/Tdoxycycline. In addition, the
IK1-opener SKA-31 had no effect on wall shear stress–induced
dilation, elicited by either high viscosity or flow, in SK3T/T
doxycycline (Figure IIC in the online-only Data Supplement).
These findings suggest that SK3 channels are particularly crucial
Figure 4 (Continued). EDHF-type vasodilation in the presence of L-NNA/indomethacin (INDO) (300 mol/L, 10 mol/L). Left panel shows
WT (IK1//SK3/), IK1//SK3/, IK1//SK3T/Tdoxycycline (n7 to 8), and right panel shows IK1//SK3T/Tdoxycycline (n9), IK1//
SK3T/Tdoxycycline (n6), and IK1//SK3T/Tdoxycycline (n5). C, left, Potentiation of acetylcholine-induced EDHF-type vasodilation in
IK1//SK3T/Tdoxycycline by the IK1-opener SKA-31 (500 nmol/L; Ve indicates vehicle [dimethyl sulfoxide]; n4 each). Insert shows prolon-
gation of responses (area under curve [AUC]) to 90-second exposure to acetylcholine in the presence of SKA-31. Right panel displays repre-
sentative tracings. Note that time span of the experiment is considerably longer because of the enhanced duration of dilations in the pres-
ence of SKA-31. D, Concentration-response curves of acetylcholine-induced vasodilation in CA in the presence of NO (absence of blockers)
in IK1//SK3/, IK1/SK3/, and IK1//SK3T/Tdoxycycline (n5 per group, left) and in IK1//SK3T/Tdoxycycline, IK1//SK3T/T
doxycycline, and IK1//SK3T/Tdoxycycline (n5 each group, right). Inserts visualize differences at 10 nmol/L acetylcholine. Values are given
as meanSEM. *P0.05, **P0.01 vs WT; #P0.05, ##P0.01 vs IK1//SK3/ in B, 1-way ANOVA followed by Newman-Keuls post hoc
test. E, Impact of combined IK1/SK3 deficiency on acetylcholine-induced vasodilation in resistance-sized arterioles in the cremaster microcir-
culation (illustrated in scheme on right). Left, Concentration-response curves in WT (IK1//SK3/) and IK1//SK3T/Tdoxycycline mice in
the presence of L-NNA/indomethacin (30 mol/L, 3 mol/L) (EDHF-type dilation) and in the absence of blockers. Right, Impact of IK1 or SK3
deficiency as well as SK3 overexpression on acetylcholine-induced EDHF-type vasodilation. Concentration-response curves in WT (IK1//
SK3/), IK1//SK3T/Tdoxycycline, IK1//SK3/, and IK1/SK3T/Tdoxycycline (n26 to 59 arterioles in 4 to 6 animals for each geno-
type). Values are given as meanSEM. *P0.05, **P0.01 vs WT, 1-way ANOVA followed by Bonferroni post hoc test; #P0.05 vs same
genotype without blockers, paired t test.
Figure 5. Impact of IK1 and/or SK3 deficiency on wall shear
stress–induced vasodilation of CA in the presence (A) and
absence (B) of L-NNA/indomethacin (INDO). Numbers (n) in
charts refer to number of CAs. Note that inhibition of NO and
prostacyclin synthesis strongly reduced dilation. For wall shear
stress–induced vasodilation, the viscosity of the perfusion
medium was increased from 0.7 to 2.9 mPa by adding 5% dex-
tran, which enhanced wall shear stress in CA from 3 to 7
dyne/cm2. Dox indicates doxycycline. Values are given as
meanSEM. *P0.05, **P0.01 vs WT, 1-way ANOVA followed
by Newman-Keuls post hoc test.
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for EDHF/NO-mediated dilations of CA to wall shear stress
stimulation.
Combined IK1 and SK3 Suppression Increases
Arterial Blood Pressure
We next assessed whether the loss of both endothelial KCa
channels and thus of EDHF signaling mediated by IK1 and
SK3 alters systemic blood pressure. For this purpose, we
conducted continuous telemetric blood pressure measure-
ments for at least 3 days in mice of both genders after
doxycycline treatment (6 days) (Figure 6A). WT had a
mean arterial pressure of 1001 mm Hg, which was unaf-
fected by doxycycline administration (992; n5). SK3T/T
doxycycline (n5) had a comparable mean arterial pressure
of 1021 mm Hg, whereas SK3T/Tdoxycycline had an
elevated mean arterial pressure of 1061 mm Hg (P0.01
versus WT; P0.05 versus SK3T/Tdoxycycline). Likewise,
IK1/ had a higher mean arterial pressure of 1081 mm Hg
(P0.01 versus WT), similar to a previous report.20
Doxycycline administration did not alter mean arterial
pressure in IK1/ (1075; n3). However, IK1//SK3T/T
doxycycline exhibited an even higher mean arterial pressure
of 1101 mm Hg (P0.001 versus WT; P0.05 versus
SK3T/Tdoxycycline, but not significantly different from
IK1/ [P0.15]). Doxycycline removal (2 weeks) lowered
mean arterial pressure to 1051 mm Hg in these animals
(n5; P0.05 versus IK1//SK3T/Tdoxycycline), but
mean arterial pressure was still higher than in the WT
(P0.05). In addition, in IK1//SK3T/T, which never re-
ceived doxycycline, mean arterial pressure was lower
(1041 mm Hg) than in the doxycycline-administered group
(P0.05) but also higher than in the WT (P0.05; Figure
6A). This indicated that overexpression of SK3 in IK1//
SK3T/Tdoxycycline reduced mean arterial pressure but was
Figure 6. Arterial blood pressure in IK1/SK3-deficient mice. A, Telemetric measurements (over 72 hours) of mean arterial blood pres-
sure (MAP), heart rate, pulse pressure, and locomotor activity in WT (IK1//SK3/; n8; 4 males/4 females), IK1//SK3T/T
doxycycline (Dox) (n6; 4 males/2 females), IK1//SK3/ (n6; 2 males/4 females), IK1//SK3T/Tdoxycycline (n9; 5 males/4
females), and IK1//SK3T/Tdoxycycline (n5; 3 males/2 females). B, Blood pressure–lowering effect of a single injection of the IK1-
opener SKA-31 (30 mg/kg IP in IK1//SK3T/Tdoxycycline mice; n4). Ctrl indicates 24-hour mean arterial pressure before application.
C, Circadian variation of mean arterial pressure and impact of physical activity on mean arterial pressure in the different genotypes.
Mean arterial pressure at night and daytime (on left) and mean arterial pressure during locomotor activity (1 count per minute) and at
rest (1 count per minute) (on right) are shown. Values are given as meanSEM. *P0.05, **P0.01, ***P0.001 vs WT in A and C;
#P0.05 vs IK1//SK3T/Tdoxycycline (A), 1-way ANOVA followed by Newman-Keuls post hoc test, paired Student t test in B.
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not able to return it to normotensive levels. In contrast,
pharmacological potentiation of IK1 in IK1//SK3T/T
doxycycline (n4) by a single injection of the IK1-opener
SKA-31 (30 mg/kg IP) lowered mean arterial pressure to
normotensive levels over 24 hours (Figure 6B).
Heart rate was similar in all genotypes (Figure 6A,
second panel). Pulse pressure (Figure 6A, third panel) was
comparable in SK3T/Tdoxycycline and WT but elevated in IK1/,
IK1//SK3T/Tdoxycycline, and IK1//SK3T/Tdoxycycline.
Locomotor activity (Figure 6A, fourth panel) was similar in
SK3T/Tdoxycycline and WT and tended to be higher in IK1/
and IK1//SK3T/Tdoxycycline (P0.08 and P0.09 versus
WT, respectively). SKA-31 injections in IK1//SK3T/T
doxycycline did not significantly alter heart rate, pulse
pressure, and locomotor activity (Figure III in the online-only
Data Supplement), although a trend toward lower values was
observed.
Further analysis of circadian variation of blood pressure
revealed that the enhancement of mean arterial pressure
in the SK3T/Tdoxycycline, IK1/, and IK1//SK3T/T
doxycycline was mainly caused by a higher mean arterial
pressure in the dark period (Figure 6C, left) and during
locomotor activity (Figure 6C, right).
Discussion
Endothelial IK1 and SK3 channels have been hypothesized to
contribute to EDHF signaling mainly on the basis of phar-
macological evidence. However, the contribution of the
EDHF dilator system to arterial tone in vivo and to systemic
blood pressure control has not been elucidated previously.
Therefore, we generated IK1//SK3T/T mice in which activa-
tion of a tetracycline-based genetic switch21 by doxycycline
treatment effectively abolished SK3 expression, resulting in
deficiency of both endothelial KCa channels. This approach
enabled us to study the effect of deficiency of both channels
on endothelium-dependent dilation and blood pressure con-
trol in vivo as well as the potential rescuing effects of SK3
overexpression and of pharmacological potentiation of IK1
activity in mice lacking the respective other channel. We
demonstrate that KCa currents are mediated by SK3 and IK1
(Figure 2). However, despite their equal ability to generate
endothelial KCa currents, the 2 channels make distinct contri-
butions to acetylcholine-induced EDHF-mediated smooth
muscle hyperpolarization. The activation of IK1 seems to be
more important because its absence impaired the hyperpolar-
ization of smooth muscle more severely than the loss of SK3
alone (Figure 3). However, SK3 channels also contribute to
smooth muscle hyperpolarization as demonstrated by the fact
that lack of SK3 alone slightly reduces hyperpolarization and
further impairs the reduced hyperpolarization response in
IK/. In keeping with this finding, strong overexpression of
SK3 in IK1//SK3T/Tdoxycycline (enhancing the endothe-
lial KCa currents10-fold) restored the acetylcholine-induced
smooth muscle hyperpolarization to near-normal values de-
spite the lack of IK1. Conversely, potentiation of IK1 activity
by the IK1-opener SKA-31 strongly enhanced hyperpolariza-
tion in IK1-expressing and SK3-deficient mice to above the
level seen in WT, thus further demonstrating a key role
of IK1 in mediating acetylcholine-induced smooth muscle
hyperpolarization.
The different roles of IK1 and SK3 became further appar-
ent in the EDHF dilator responses in the different genotypes
(Figure 4A). The loss of IK1 alone resulted in a pronounced
effect at intermediate acetylcholine concentrations. However,
the additional deletion of SK3 in IK1//SK3T/Tdoxycycline
further impaired dilations, highlighting the importance of
both channels for generating EDHF-type dilations. In contrast
to IK1 deficiency, the suppression of SK3 in IK1-expressing
mice was without appreciable effects. However, the impaired
dilation in IK1 deficiency could be augmented by overex-
pression of SK3 but hardly reached WT levels. Moreover,
overexpression of SK3 in IK1 WT did not produce a larger
EDHF response, which suggests that the importance of SK3
is only demonstrated in the absence of IK1. In contrast,
potentiation of IK1 by SKA-31 clearly enhanced the EDHF
response in SK3-deficient mice (shown here), as well as in
WT, although not in IK1/, as shown recently by us.25
Importantly, the present experiments in the microcirculation
clearly validate the requirement of both IK1 and SK3 for the
EDHF dilator response in resistance-sized arterioles in vivo.
Only at high concentrations of acetylcholine was a remaining
small dilation observed, which was comparable to responses
in conduit arteries. Moreover, the findings in mice lacking
either IK1 or SK3 or overexpressing SK3 during IK1 defi-
ciency are in agreement with the findings in the conduit artery
and further underscore a major role of IK1 in the EDHF
response to acetylcholine, whereas SK3 contributes only in
the absence of IK1.
Thus, these findings support the notion that IK1 in partic-
ular is of pivotal importance for the EDHF response elicited
by stimulation of G-protein–coupled receptors (by acetylcho-
line) and subsequent Ca2 release from the endoplasmic
reticulum. The distinct roles may be related to the recently
suggested spatial separation of the 2 channels within in the
endothelium: SK3 at endothelial cell junctions29 (and perhaps
in caveolae30) and IK1 at endothelial projections through the
holes in the elastic lamina (also the sites of myoendothelial
gap junctions29) and in close proximity to the endoplasmic
reticulum.31 Thus, acetylcholine-triggered Ca2 release events
(recently termed Ca2 pulsars31) could preferentially activate
colocalized IK1 channels.
Depending on the type of vessel, the contribution of NO
and prostaglandins in endothelium-dependent dilations varies
substantially.4,18,32 In the conduit vessels used here, NO
contributes considerably to acetylcholine-induced dilation.20
At maximal acetylcholine stimulation and with unimpeded
NO synthesis, the dilation of the CA remains intact despite
the lack of KCa channels (Figure 4D). However, at lower
acetylcholine concentrations, dilations were reduced in SK3-
and IK1/SK3-deficient mice despite intact NO synthase,
suggesting that KCa channels, in particular SK3, are required
for NO synthesis. In contrast to CA, the lack of KCa channels
substantially reduces dilations in the murine microcirculation
with a functioning NO system (Figure 4E), highlighting the
special importance of the EDHF-dependent dilation in arte-
rioles, the minor role of NO-dependent mechanisms,32 and the
inability of NO to compensate for the lack of KCa channels. This
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suggests that, at least in the macrocirculation, an endothelial
hyperpolarization contributes to the activation of NO syn-
thase possibly by providing the driving force for Ca2 influx,
as suggested previously.33 Interestingly, SK3 channels were
found to be more important in this phenomenon because both
SK3- and IK1/SK3-deficient mice exhibited reduced vasodi-
lations to low concentrations of acetylcholine, whereas IK1-
deficient mice did not show impairment.
The differential roles of the 2 endothelial KCa channels are
further highlighted by the finding that SK3 deficiency but not
IK1 deficiency impaired dilations of CA in response to shear
stress stimulation by increasing either viscosity or flow. The
attenuation in animals lacking SK3 was evident in the
presence as well as in the absence of NO, suggesting that SK3
is required not only for the EDHF-mediated but also for the
larger NO-mediated flow-induced dilation. Overexpression of
SK3 in either IK1-lacking or IK1-expressing mice failed to
further increase shear stress–induced dilation, suggesting
either that basal SK3 expression levels are sufficient to
produce hyperpolarization or that the ensuing vasodilation
simply abrogates the mechanical stimulus.34 Potentiation of
IK1 functions by SKA-31 in SK3-deficient mice was inef-
fective to restore the response, which further supports the
notion that IK1 is not activated by shear stress–induced
[Ca2]i increases. Thus, SK3, unlike IK1, seems to be crucial
for adequate endothelial mechanotransduction in response to
shear stress stimulation and may therefore be important for
tonic EDHF activity and endothelial NO formation under
continuous blood flow in vivo.
Taken together, our data suggest that activation of IK1 and
SK3 in a stimulus-dependent fashion constitutes the major
electric trigger for EDHF dilator responses. The importance
of the SK3/IK1-initiated EDHF system for blood pressure
control is supported by our finding of a significant increase in
blood pressure in mice lacking 1 or both channels. Intrigu-
ingly, the defect in the SK3/IK1 EDHF dilator system
increased blood pressure mainly during locomotor activity,
suggesting that the EDHF system is especially required to
ensure adequate vasoregulation and thereby blood pressure
control during physical activity. Interestingly, pulse pressure
was elevated in mice lacking IK1 but not in SK3-lacking
animals (for additional discussion, see the online-only Data
Supplement). Because the combined loss of SK3 and IK1 had
few additive effects on blood pressure, the 2 channels exert
distinct but essential roles in blood pressure control. This
hypothesis is supported by the inability of SK3 overexpres-
sion to completely compensate for the loss of IK1 and to
restore normal blood pressure. This may be related to a more
significant role of IK1 in EDHF-type dilation, which is
underscored by the ability of the IK1-opener SKA-31 to
return the elevated blood pressure in SK3-deficient and
IK1-expressing mice back to normotensive levels. Addition-
ally, SKA-31 lowered blood pressure in WT mice but not the
elevated blood pressure in IK1-deficient mice,25 which empha-
sizes its 10-fold higher potency for IK1 over SK3. Alternatively,
both channels may use distinct downstream EDHF signaling
pathways, ie, electrotonic coupling mechanisms (SK3) and/or
K release (IK1), as suggested recently.3,5,12,17,27,29 Moreover,
SK3 may add to blood pressure control by exerting a tonic
influence on vascular tone,22 possibly by its role in NO dilator
responses to low levels of vasoactive factors and flow
alterations.
In summary, the present study demonstrates that EDHF-
mediated dilations are virtually absent in SK3/IK1-deficient
mice and that these mice exhibit enhanced blood pressure.
The analysis of these animals further provides substantial
evidence that SK3 and IK1 play distinct roles in vessel
physiology despite their overlapping function as endothe-
lial KCa channels. We suggest that SK3/IK1-deficient mice
represent an “EDHF knockout,” which may provide a
useful model to study the physiological actions of putative
EDHFs4,5,11 in the circulation.
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CLINICAL PERSPECTIVE
The arterial endothelium modulates vascular tone and blood pressure by releasing nitric oxide and prostacyclin, as well as
by a third factor or signalling pathway termed “endothelium-derived hyperpolarizing factor” (EDHF). Herein, we show that
EDHF-type signalling and dilations strongly depend on the presence of endothelial KCa-channels (SK3/IK1) and that their
lack has a significant impact on vascular dilation and blood pressure control in vivo. Thus, SK3/IK1-deficient mice may
help to shed light on the role of EDHFs in cardiovascular pathologies such as atherosclerosis, hypertension, and stroke.
Strikingly, the EDHF-potentiating effects of the IK1-opener SKA-31 and the partial rescue of EDHF deficiency by
overexpression of SK3 returned blood pressure to almost normotensive levels, suggesting that selective pharmacological
activators of endothelial SK3 and IK1 may be of therapeutic value in the treatment of hypertension. In support of this
hypothesis, we recently demonstrated that SKA-31 significantly lowers blood pressure in angiotensin II hypertensive mice.
Pharmacological activation of endothelial KCa channel activity might be particularly desirable in situations where the EDHF
response is impaired because of a decreased activity of endothelial KCa channels, as has been reported after
cardiopulmonary bypass, balloon catheter angioplasty, and chronic renal failure.
2332 Circulation May 5, 2009
 by guest on January 14, 2017
http://circ.ahajournals.org/
D
ow
nloaded from
 
John P. Adelman, Heike Wulff, Cor de Wit, Joachim Hoyer and Ralf Köhler
Brajesh P. Kaistha, Michael Kacik, Anna-Lena Hasenau, Ivica Grgic, Han Si, Chris T. Bond, 
Sebastian Brähler, Anuradha Kaistha, Volker J. Schmidt, Stephanie E. Wölfle, Christoph Busch,
Hyperpolarizing Factor Vasodilator Pathway and Causes Hypertension
Genetic Deficit of SK3 and IK1 Channels Disrupts the Endothelium-Derived
Print ISSN: 0009-7322. Online ISSN: 1524-4539 
Copyright © 2009 American Heart Association, Inc. All rights reserved.
is published by the American Heart Association, 7272 Greenville Avenue, Dallas, TX 75231Circulation 
doi: 10.1161/CIRCULATIONAHA.108.846634
2009;119:2323-2332; originally published online April 20, 2009;Circulation. 
 http://circ.ahajournals.org/content/119/17/2323
World Wide Web at: 
The online version of this article, along with updated information and services, is located on the
 http://circ.ahajournals.org/content/suppl/2009/04/17/CIRCULATIONAHA.108.846634.DC1.html
Data Supplement (unedited) at:
  
 http://circ.ahajournals.org//subscriptions/
is online at: Circulation  Information about subscribing to Subscriptions:
  
 http://www.lww.com/reprints
 Information about reprints can be found online at: Reprints:
  
document. Permissions and Rights Question and Answer this process is available in the
click Request Permissions in the middle column of the Web page under Services. Further information about
Office. Once the online version of the published article for which permission is being requested is located, 
 can be obtained via RightsLink, a service of the Copyright Clearance Center, not the EditorialCirculationin
 Requests for permissions to reproduce figures, tables, or portions of articles originally publishedPermissions:
 by guest on January 14, 2017
http://circ.ahajournals.org/
D
ow
nloaded from
 
Supplemental Material 
 
 
Material and Methods 
 
Transgenic animals: SK3T/T and IK1-/- mice1,2 were interbred in a specific-pathogen-
free environment of our local animal core facility. Mice received standard mice chow and 
water ad libitum. Heterozygous IK1+/-/SK3T/+ breeding pairs produced offspring at the 
predicted Mendelian frequencies. All types of double heterozygous transgenic and double 
transgenic mice were of normal appearance, viable, fertile and showed no obvious 
neurological or behavioral defects. Genotyping was performed with genomic DNA using 
standard PCR and primers: Primers were: FP: 5’-ATGGACACTTCTGGGCACTT-3’; RP 
5’-AGAGTGCAACAGACCAGGAT-3’ for SK3+/+ and SK3T/T alleles. Forward and 
reverse primers for IK1+/+ and IK1-/- alleles are stated elsewhere2. For suppression of SK3 
expression, mice received Dox in the drinking water (2 mg/ml in 2% sucrose) for at least 6 
days before experiment. The investigation conforms to the Guide for the Care and Use of 
Laboratory Animals published by the US National Institutes of Health (NIH Publication 
No. 85-23, revised 1996) and animal protocols were approved by the local authorities (Ref.-
No.V54-19c20-15MR20/11). 
 
Western Blotting: Mouse brains (for SK3) and livers (for IK1) from each genotype 
were homogenized in buffer (50 mM Tris, 1 mM EDTA, 2 mM DTT, 0.2 µM benzamidine, 
50 mM leupeptin, 0.5 mM PMSF, 0.1 mg/ml trpysin inhibitor pH 8.0). Debris and nuclear 
material were removed by centrifugation at 1000×g for 2 min. Membrane proteins were 
collected by centrifugation at 20,000×g for 45 min, resuspended in homogenization buffer 
and quantified using the Bio-Rad protein assay. 30 µg of membrane proteins were 
electrophoresed on 8-12 % sodium dodecylsulfate–polyacrylamide gels, and electro-
phoretically transferred to nitrocellulose membranes (Trans-Blot, all from Bio-Rad, 
Munich, Germany). Membranes were then blocked in 5% non fat dried milk in TBST (10 
mM Tris-HCl, pH 7.5, 100 mM NaCl, 0.1% Tween 20) for one hour at room temperature. 
An anti-SK3 antibody was purchased from Alomone Labs (Jerusalem, Israel). For detection 
 2
of IK1, we used a rabbit antibody directed against the 28 amino acids of the n-terminus 
(MGGDLVLGLGALRRRKRLLEQEKSLAGW, position 1-28) of the channel (Pineda 
antibody services, Berlin). Affinity purification of the monospecific IgG fraction was made 
with the peptide covalent coupled to Sepharose 6B via the cysteine residue of the peptide. 
The elution of the specific antibodies was carried out with 0.2 M glycin buffer pH 3.0. 
Primary antibodies diluted in TBST (anti-IK1, 1:200; anti-SK3, 1:200) were applied 
overnight at 4°C. After rinsing with TBST, the membranes were incubated with a 
peroxidase-conjugated goat anti-rabbit antiserum (1:10,000 GE Healthcare Europe, 
Freiburg, Germany) for one hour at room temperature. Immunolabelled proteins were 
visualized by ECL advance Western blot detection system (GE Healthcare). Equal loading 
of proteins was validated by stripping and re-probing the Western blots with an anti-α-
tubulin antibody (H-300, 1:200; Santa Cruz). 
 
Immunohistochemistry: For detection of IK1 and SK3 proteins, CA were fixed by 
transcardiac perfusion with 10% neutral-buffered formalin and embedded in paraffin. After 
pre-incubation with 5% BSA, the cross-sections (7µm) were blocked with 30% avidin and 
biotin (Vector Laboratories; Wertheim-Bettingen, Germany) in 1% BSA for 30 min. 
Sections were then immunostained using polyclonal antibodies against IK1 (H-120, 1:50 
dilution) and SK3 (H-45, dilution 1:50; both from Santa Cruz Biotechnology, Heidelberg, 
Germany). Detection was performed by using the Vectastain Elite ABC Kit (Vector 
Laboratories) and the Vector SG Substrate Kit for immunoperoxidase reaction according to 
the manufacturer’s instruction. Labelled sections of CA were photographed at 400x using 
an AxioCam MRm camera mounted on an AxioObserver.Z1 microscope in ApoTome 
mode (Zeiss, Jena, Germany). 
 
Electrophysiology: Membrane currents in freshly isolated carotid artery endothelial 
cells2 (CAEC) were determined with an EPC-9 patch-clamp amplifier (HEKA, 
Lambrecht/Pfalz, Germany) using voltage ramps (1000 ms; -100 to +40 mV). For 
activation of IK1/SK3-currents, CAEC were dialyzed with a KCl-pipette solution 
containing 3 µM [Ca2+]free (in mM): 140 KCl, 1 Na2ATP, 1 MgCl2, 2 EGTA, 1.91 CaCl2, 
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and 5 HEPES, pH 7.2. The NaCl bath solution contained (mM): 137 NaCl, 4.5 Na2HPO4, 3 
KCl, 1.5 KH2PO4, 0.4 MgCl2, 0.7 CaCl2, and 10 glucose (pH 7.4). Smooth muscle 
membrane potentials in CA (preconstricted with 1 µM phenylephrine (PE) and pressurized 
to 80 mmHg) were recorded in the presence of Nω-nitro-L-arginine (L-NNA, 300 µM), 
indomethacin (INDO, 10 µM) by standard sharp electrode technique using a BA-1S 
amplifier (npi electronic, Tamm, Germany). Sharp electrodes filled with 0.5 M KCl (tip 
resistance 80-100 MΩ)  were inserted from the adventitial side and a sharp deflection of the 
zero potential towards negative values indicated successful cell penetration. In experiments 
using the IK1-opener SKA-31 (naphtho[1,2-d]thiazol-2-ylamine) 3, SKA-31 (500 nM) was 
added to the bath solution (patch-clamp experiments) and to the perfusion buffer 
(membrane potential measurements and myography) and was present throughout 
experiments. For control experiments, solutions contained the vehicle (DMSO, 1‰). 
 
Vessel studies: Pressure myography in CA was performed as described previously2. 
Bath and perfusion solution contained (in mM): 145 NaCl, 1.2 NaH2PO4, 4.7 KCl, 1.2 
MgSO4, 2 CaCl2, 5 glucose, 2 pyruvate, 3 MOPS buffer. (pH 7.4 at 37°C). CA were 
pressurized to 80 mmHg and continuously perfused at a flow rate of 0.6 ml/min. CA were 
pre-constricted with 1 µM PE and perfused with acetylcholine (ACh; 1 nM to 10 µM) in 
the presence and absence of L-NNA (300 µM) and INDO (10 µM). Diameter changes of 
CA were expressed as a percentage of the maximal dilation to 10 µM sodium nitroprusside 
(SNP). To measure wall shear stress(WSS)-mediated vasodilation, the viscosity of the 
perfusion medium was increased from 0.7 to 2.9 mPa*s by adding 5% dextran which 
enhanced wall shear stress in CA from ~3 to 7 dyne/cm2 (without increasing flow rate). As 
alternative methods to enhance WSS, flow was enhanced from almost static conditions 
(~30 µl/min) to physiologically relevant levels (600 µl/min) by increasing the pressure 
gradient between inflow and outflow capillaries to 20 mmHg within ~5 secs. The shear 
stress increased from ~0.1 to 3 dyne/cm2. The mean intraluminal pressure remains constant 
at 80 mmHg under these conditions. Shear stress was mathematically estimated according 
to the Hagen-Poiseuille law: τ=4ηQ/πr3; τ=shear stress; η=viscosity; Q=flow, and r=radius. 
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Intravital microscopy: Arteriolar diameters were measured using intravital 
microscopy in the cremaster microcirculation before and after superfusion of ACh, 
adenosine, and SNP applied at increasing concentrations as described previously 4. In brief, 
animals were anesthetized by intraperitoneal injection of medetomidin (0.5 mg/kg), 
fentanyl (0.05 mg/kg) and midazolam (5 mg/kg), followed by continuous infusion via a 
catheter placed in the jugular vein. Mice were intubated by tracheotomie to ensure airway 
patency and their esophageal temperature was maintained at 37°C by conductive heat. 
Cremaster muscle was prepared as described 4 and superfused with bicarbonate-buffered 
(pH 7.4, 34° C) saline solution (in mM: Na+ 138, K+ 5, Ca2+ 2.5, Mg2+ 1.2, Cl- 127, HCO3- 
20, SO42- 1.2, H2PO42- gassed with 5% CO2 and 95% N2 (pCO2 ≈ 40 mm Hg, pO2 ≈ 30 mm 
Hg). Animals were transferred to a microscope stage (Axioskop FS, Zeiss, Göttingen, 
Germany) equipped with a charge-coupled video camera. Microscopic images were 
displayed on a monitor at 700-fold magnification and recorded on videotape for later 
measurement of luminal diameter after digitization. The resolution after digitization was 
about 1 µm. Responses were restudied in the presence of L-NNA (30 µM) and INDO (3 
µM). Dilator responses are given as the percentage of maximal dilation 4. 
 
Telemetry: Mice were allowed to recover for 9 days after implantation of a TA11PA-
C10 pressure transducer into the left carotid artery (Data Sciences International (DSI), St 
Paul, Minnesota, USA). Thereafter, pressure values, heart rate, and locomotor activity were 
continuously recorded for at least 3 consecutive days in Dox-treated or untreated mice. The 
values of the 3-day recording were averaged and used for statistical analysis. Further 
analysis of the data (day/night distribution, activity/MAP relationship) was done using the 
DSI software and Origin®6.1. In experiments using SKA-31, SKA-31 was dissolved in 
peanut oil and 30mg/kg was injected i.p. (injection volume 100μl) at the end of light period. 
Telemetry data were recorded 24h before and 24h after injection. The respective 24h-
recordings were averaged and used for statistical analysis. 
 
Statistics: Data are given as mean ± SEM. Statistical calculations were done with 
Origin®6.1 and SigmaStat©2.03. If not stated otherwise, one-way ANOVA followed by 
 5
the Newman-Keuls-post hoc test was used to assess differences between groups. The paired 
Student’s t-Test was used if observations were obtained in the same animal or vessel before 
and after a treatment (e.g. assessment of blood pressure changes after SKA-31 injections). 
P-values <0.05 were considered significant. 
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Suppl. Fig. 1: CA diameters (normalized to body weight) in response to SNP (10 μM), 60 mM K+ and to PE 
(1 μM) in the different genotypes and in the presence (A) or absence of blockers of NO-synthase and 
cyclooxygenase (B). Data are given as mean ± SEM.
Suppl. Fig. 2: Vasodilation of CA in response to flow stimulation depends on SK3-expression. Flow-
induced vasodilation in the presence (A) and absence (B) of L-NNA and INDO. Data are given as mean ±
SEM; *P<0.05, **P<0.01, One-Way-ANOVA & Newman-Keuls-post hoc test. C) SKA-31 (500 nM) did not 
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significantly alter shear stress-induced vasodilation in SK3-deficient mice (IK1+/+/SK3T/T + Dox, n=4). 
Dashed line indicates control responses in wt animals. For control values (high viscosity) see also Fig. 5A. 
Ve = vehicle (DMSO). Data are given as mean ± SEM; SKA-31 (carotid arteries, n=4) vs. Ve (carotid 
arteries, n=4): n.s., Student’s t-test.
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Suppl. Fig. 3:
 
 
 
Suppl. Fig. 3: Effect of a single injection of SKA-31 (30 mg/kg/ i.p.) on heart rate, pulse pressure, and 
omotor activity over 24 hrs after injection. Ctrl = 24 hrs means ahead of treatment;  n.s. = not 
ignificant, paired Student’s t-test.
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Suppl. Fig. 4: ACh-induced dilation in the absence (white symbols) or presence of L-NNA/INDO (30 and 3 
ol/L, grey symbols) in the cremaster microcirculation of different genotypes. Inhibition of NO-synthase 
 cyclooxygenase did not affect ACh-induced dilation. Only in doxycyclin-treated IK+/+/SK3T/T animals a 
all attenuation at the highest ACh-concentration was observed (B). Data in the presence of L-
DO (dashed lines) are replotted herein from Fig. 4E (right panel) for comparison. # P<0.05 vs. 
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Supplemental Discussion 
 
 
Interestingly, pulse pressure was elevated in mice lacking IK1, but not in SK3-
lacking animals. This could simply be due to enhanced mean arterial pressure as the 
compliance of the aorta decreases with increasing pressure. However, blood pressure was 
likewise elevated in animals lacking SK3 without a concomitant rise in pulse pressure, 
which argues against pressure dependency. In porcine coronary arteries pulsatile stretch 
releases EDHF and thereby modulates arterial compliance5. The current observation 
indicates a specific role of IK1 in modulating aortic compliance possibly by a related 
EDHF-type mechanism. Such a modulating effect may alter pulse-wave velocity within the 
arterial tree and wave reflection. Of note, such factors have recently been suggested to be 
independent risk factors for cardiovascular disease6. Yet, we cannot exclude the possibility 
that the enhanced arterial compliance is a consequence of the chronic pressure increase, 
which may have led also to structural changes of the arterial wall in these animals with life-
long IK1-deficiency. 
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